Kulkarni S, Nagarajan P, Wall J, Donovan D, Donell RL, Ligon AH

advertisement
Kulkarni S, Nagarajan P, Wall J, Donovan D, Donell RL, Ligon AH, Venkatachalam
S, Quade BJ. Disruption Of Chromodomain Helicase DNA Binding Protein 2
(CHD2) Causes Scoliosis. Am J Med Genet (In press)
Lu W, van Eerde AM, Fan X, Quintero-Rivera, Kulkarni S, Ferguson H, Kim H,
Sanlaville D, Andrews W, Sundaresan V , Bi W, Yan J, Giltay JC, Wijmenga C, de
Jong TP, Feather S, Woolf AS, Rao Y, Lupski J, Quade BJ, Gusella JF, Morton CC
and Maas R. Disruption of ROBO2 is associated with congenital anomalies of the
kidney and urinary tract and confers risk of vesicoureteral reflux. Am J Hum Genet.
2007: 80(4): 616-32
Goldman F, Bouharich R , Kulkarni S, Freeman S , Du H, Harrington H , Mason PJ,
Vallejo A , Bessler M. The effect of TERC haploinsufficiency on the inheritance of
telomere length. Proc Natl Acad Sci USA 2005: 102(47): 17119-17124.
Knudson M, Kulkarni S, Ballas K, Bessler M, and Goldman F. Association of
immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis
congenita. Blood 2005: 105: 682-688
Kulkarni S, Bessler M. Effect of proinflammatory cytokines on PIGAhematopoiesis. Experimental Hematology 2003: 31(9): 770-778
Mochizuki Y, He J, Kulkarni S, Bessler M, Mason PJ. Mouse dyskerin mutations
affecting mTERC levels, telomerase activity and ribosomal RNA processing. Proc
Natl Acad Sci USA 2004: 101(29): 10756-10761
Baxter EJ, Kulkarni S, Vizmanos JL, Jaju R, Martinelli G, Testoni N, Hughes G,
Calasanz MJ, Lahortiga I, Pocock CF, Dang R, Fidler C, Wainscoat JS, Boultwood J,
Cross NCP. Novel translocations that disrupt the platelet-derived growth factor
receptor β (PDGFR β) gene in BCR-ABL negative chronic myeloproliferative
disorders. British Journal of Hematology 2003: 120: 251-256
Kulkarni S, Bessler M. The effect of GPI-linked deficiency on apoptosis in mice
carrying a Piga gene in hematopoietic cells. Journal of Leukocyte Biology 2002:
72(6): 1228-33
Kulkarni S, Heath C, Parker S, Chase A, Iqbal S, Pocock CF, Kaeda J, Cwynarski K,
Goldman JM, Cross NC. Fusion of H4/D10S170 to the platelet-derived growth factor
receptor beta in BCR-ABL-negative myeloproliferative disorders with a
t(5;10)(q33;q21). Cancer Res. 2000: 60(13): 3592-3598
Kulkarni S, Reiter A, Smedley D, Goldman JM, Cross NCP. The complete
genomic structure of ZNF198 and the localisation of breakpoints in t(8;13)
myeloproliferative disorders. Genomics 1999: 55: 118-121
Kulkarni S, Grand F, Chase A, Goldman JM, Gordon M and Cross NCP. Frequent
deletion of hSNF5/INI-1, a component of SWI/SNF Complex, in chronic myeloid
leukaemia. Cancer Research 1999: 59: 3870-3874
Reiter A, Sohal J, Kulkarni S, Chase A, Macdonald DHC, Aguiar RCT, Goncalves
C, Hernandez JM, Jennings BA, Goldman JM , Cross NCP. Consistent fusion of
ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12)
myeloproliferative syndrome. Blood 1998: 92(5): 1735-1742
How GF, Lim LC, Kulkarni S, Tan LT, Cross NCP. Two patients with novel
BCR/ABL fusion transcripts (e8/a2 and e13a2) resulting from translocation
breakpoints within BCR exons. British Journal of Haematology 1999: 105: 434-436
Kulkarni S, Ammini AC, Kucheria K. Marker chromosome in a Turner patient.
Indian Journal of Human Genetics 1995: 1(2): 123-126
Download